Exicure, Inc. (NASDAQ:XCUR) Short Interest Up 479.6% in November

Exicure, Inc. (NASDAQ:XCUR) was the target of a significant growth in short interest in November. As of November 30th, there was short interest totalling 93,900 shares, a growth of 479.6% from the November 15th total of 16,200 shares. Approximately 8.5% of the company’s stock are short sold. Based on an average daily volume of 1,520,000 shares, the short-interest ratio is presently 0.1 days.

Exicure Stock Performance

NASDAQ:XCUR opened at $18.87 on Thursday. The company has a market capitalization of $49.18 million, a price-to-earnings ratio of -9.24 and a beta of 3.59. Exicure has a one year low of $1.44 and a one year high of $36.00. The stock has a 50-day simple moving average of $8.64 and a 200 day simple moving average of $3.66.

About Exicure

Exicure, Inc, an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology.